So finally, I get this photo opportunity with one incredible, inspiring and yet very humble Prof Carlos Parra- Herran @ Bagp 21st annual mtg #gynpath

What’s new in WHO 2025 ? Ahead of the 6th edition - Key note lecture by Prof Glenn McCluggage BAGP 21st annual meeting , Belfast @BAGPGynPath @ISGynP #gynpath

Let’s not forget why we are doing what we are doing !! Impactful talks on ‘ patient oriented pathology reporting ‘ by Prof Raji Ganesan and Prof Joe Rabban . @BAGPGynPath @ISGynP

Bagp 21st annual mtg Belfast Dr Richard Wong on navigating the landscape of mixed carcinomas showing the heterologous morphology and immunoprofile . @BAGPGynPath @ISGynP #gynpath

‘Attending Bagp 21st annual meeting in Belfast “What’s new in gynae pathology “ by Carlos Parra-Herran - an absolute treat ! @bagp @isgyp #gynpath

@GersonPaull_MD Here is one of the few out there 🙏🏻.

This was another case that I came across a while ago, which shows pleomorphic CIN3. There was no invasion in multiple levels examined.

Pleomorphic CIN. This is just a LG CIN showing striking pleomorphism of basal cells. Limited studies, but not associated with aggressive behaviour and may even represent a degenerative change. Can be confused for early stromal invasion when cross cut. #pathtwitter #gynpath

Prophylactic hysterectomy for LS. All benign. But saw this in one of the sections. This couldn't be fat. Could it? Have you ever come across this? #gynpath @Dramanyhassany1 @slusagar @kis_lorand @GbGynae @OBGYNPATH @DrSwatiBhardwaj @DrEstherAdler @DrGeeONE @TristanRutland7

F/50ish vaginal polyp. p16 negative. GATA3 positive in squamous, PSA negative. Do we have a name for this? Would you call it a tubulo-squamous polyp, or does the dominant glandular component speak against it? #pathtwitter #Gynpath